Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Rieger

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
Stem Cells Translational Medicine|May 31, 2022
Allogeneic Cell Combination Therapy Ameliorates Chronic Kidney Disease-Induced Heart Failure with Preserved Ejection FractionAngela C Rieger, Bryon A Tompkins, Makoto Natsumeda, et al.
Journal of the American College of Cardiology|November 18, 2017
A Combination of Allogeneic Stem Cells Promotes Cardiac RegenerationMakoto Natsumeda, Victoria Florea, Angela C Rieger, et al.
Circulation Research|September 20, 2017
Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study)Victoria Florea, Angela C Rieger, Darcy L DiFede, et al.
Journal of the American College of Cardiology|November 19, 2016
Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM TrialJoshua M Hare, Darcy L DiFede, Angela C Rieger, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
Stem Cells Translational Medicine|May 31, 2022
Allogeneic Cell Combination Therapy Ameliorates Chronic Kidney Disease-Induced Heart Failure with Preserved Ejection FractionAngela C Rieger, Bryon A Tompkins, Makoto Natsumeda, et al.
Journal of the American College of Cardiology|November 18, 2017
A Combination of Allogeneic Stem Cells Promotes Cardiac RegenerationMakoto Natsumeda, Victoria Florea, Angela C Rieger, et al.
Circulation Research|September 20, 2017
Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study)Victoria Florea, Angela C Rieger, Darcy L DiFede, et al.
Journal of the American College of Cardiology|November 19, 2016
Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM TrialJoshua M Hare, Darcy L DiFede, Angela C Rieger, et al.
Pageof 9